ETRA Insider Trading Activity and SEC Form 4 Filings
ETRA insider trading summary
Over the past 12 months, insiders at Electra Therapeutics, Inc. (ETRA) reported 48 open-market purchases worth $94.4M by 4 insiders and no sales on SEC Form 4. Net insider buying was $94.4M.
Latest ETRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | OrbiMed Genesis GP LLC | Director | Buy | $915K (125,200 @ $7.31) |
| Nov 5, 2026 | Orbimed Advisors LLC | Director | Buy | $915K (125,200 @ $7.31) |
| Nov 5, 2026 | OrbiMed Genesis GP LLC | Director | Buy | $226K (30,891 @ $7.31) |
| Nov 5, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $915K (125,200 @ $7.31) |
| Nov 5, 2026 | Carl L Gordon | Director | Buy | $226K (30,891 @ $7.31) |
| Nov 5, 2026 | Carl L Gordon | Director | Buy | $915K (125,200 @ $7.31) |
| Nov 5, 2026 | Orbimed Advisors LLC | Director | Buy | $226K (30,891 @ $7.31) |
| Nov 5, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $226K (30,891 @ $7.31) |
| Nov 4, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $35K (5,000 @ $7.07) |
| Nov 4, 2026 | Orbimed Advisors LLC | Director | Buy | $35K (5,000 @ $7.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.